Q3): Human xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can further catalyze the oxidation of xanthine to uric acid. For the treatment of hyperuricemia and gout, several medications are used to inhibit the activity of xanthine oxidase and reduce the production of uric acid. You are a biochemist and just discovered a chemical that can inhibit the activity of the human xanthine oxidase. When analyzing its mode of inhibition, you found that the enzyme inhibitor complex requires 450 J.mol-1 to dissociate and that it displays kinetics somehow similar to noncompetitive inhibition. You sent your inhibitor to the ministry of health for approval as a medication for gout. Based on the data provided, are they going to authorize it as a medication or not? Explain?

Biochemistry
6th Edition
ISBN:9781305577206
Author:Reginald H. Garrett, Charles M. Grisham
Publisher:Reginald H. Garrett, Charles M. Grisham
Chapter26: Synthesis And Degradation Of Nucleotides
Section: Chapter Questions
Problem 11P: The Catabolism of Uric Acid Write a balanced equation for the oxidation of uric acid to glyoxylic...
icon
Related questions
icon
Concept explainers
Question

NOTE: the enzyme-inhibitor complex requires 450 joule/mol to dissociate
JOULE/MOL

Q3): Human xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can
further catalyze the oxidation of xanthine to uric acid. For the treatment of hyperuricemia and
gout, several medications are used to inhibit the activity of xanthine oxidase and reduce the
production of uric acid. You are a biochemist and just discovered a chemical that can inhibit
the activity of the human xanthine oxidase. When analyzing its mode of inhibition, you found
that the enzyme inhibitor complex requires 450 J.mol-1 to dissociate and that it displays kinetics
somehow similar to noncompetitive inhibition. You sent your inhibitor to the ministry of health
for approval as a medication for gout. Based on the data provided, are they going to authorize
it as a medication or not? Explain?
Transcribed Image Text:Q3): Human xanthine oxidase catalyzes the oxidation of hypoxanthine to xanthine and can further catalyze the oxidation of xanthine to uric acid. For the treatment of hyperuricemia and gout, several medications are used to inhibit the activity of xanthine oxidase and reduce the production of uric acid. You are a biochemist and just discovered a chemical that can inhibit the activity of the human xanthine oxidase. When analyzing its mode of inhibition, you found that the enzyme inhibitor complex requires 450 J.mol-1 to dissociate and that it displays kinetics somehow similar to noncompetitive inhibition. You sent your inhibitor to the ministry of health for approval as a medication for gout. Based on the data provided, are they going to authorize it as a medication or not? Explain?
Expert Solution
steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Enzyme kinetics
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Biochemistry
Biochemistry
Biochemistry
ISBN:
9781305577206
Author:
Reginald H. Garrett, Charles M. Grisham
Publisher:
Cengage Learning